PHARMACODYNAMICS AND PHARMACOKINETICS OF CYCLOSPORINE-A IN THE NEWBORN PIG

被引:4
|
作者
TSAO, PW
ITO, S
WONG, PY
RADDE, IC
BRYSON, S
YOUNG, DS
CASPI, J
DIAZ, RJ
MARTELL, MF
AUGUSTINE, JM
WILSON, GJ
COLES, JG
机构
[1] HOSP SICK CHILDREN,DEPT CARDIOVASC RES,DIV CARDIOVASC SURG,RES INST,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA
[2] HOSP SICK CHILDREN,DEPT PATHOL,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA
[3] TORONTO HOSP,DEPT CLIN CHEM,DIV CLIN PHARMACOL,TORONTO,ON,CANADA
[4] UNIV TORONTO,DEPT PHARMACOL,TORONTO M5S 1A1,ONTARIO,CANADA
来源
关键词
CYCLOSPORINE-A PHARMACOKINETICS; NEWBORN PIG; IMMUNOSUPPRESSION; LYMPHOCYTE PROLIFERATION;
D O I
10.1159/000480594
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The disposition kinetics of cyclosporin A in the neonates as well as age-related differences in lymphocyte responses to cyclosporin A are unknown. A single intravenous infusion of cyclosporin A was given to neonatal (2.5 or 5 mg/kg) and mature pigs (10 mg/kg) and blood cyclosporin A levels were measured by RIA. The neonates had longer elimination half-life and lower drug clearance than mature animals. Suppression in lymphocyte proliferation was only observed in mixed lymphocyte reaction and phytohemagglutinin-stimulated cultures of the 2-hour samples from neonates receiving 5 mg/kg. We conclude that neonatal pigs exhibit different cyclosporin A pharmacokinetics and show higher sensitivity to cyclosporin A than mature animals.
引用
收藏
页码:20 / 25
页数:6
相关论文
共 50 条
  • [1] AGE-RELATED DIFFERENCES IN CYCLOSPORINE-A PHARMACOKINETICS AND PHARMACODYNAMICS
    YOUNG, DS
    TSAO, PW
    BRYSON, S
    WONG, PY
    DIAZ, RJ
    CASPI, J
    AUGUSTINE, JM
    MARTELL, MF
    WILSON, GJ
    SHORE, A
    COLES, JG
    [J]. CIRCULATION, 1990, 82 (04) : 714 - 714
  • [2] PHARMACOKINETICS AND PHARMACODYNAMICS OF CYCLOSPORINE
    KAHAN, BD
    [J]. TRANSPLANTATION PROCEEDINGS, 1989, 21 (03) : 9 - 15
  • [3] Pharmacokinetics and pharmacodynamics in the newborn
    I. Eberini
    [J]. Veterinary Research Communications, 2008, 32 : 77 - 80
  • [4] Pharmacokinetics and pharmacodynamics in the newborn
    Eberini, I.
    [J]. VETERINARY RESEARCH COMMUNICATIONS, 2008, 32 (Suppl 1) : S77 - S80
  • [5] COMPARISON OF CYCLOSPORINE-A AND CYCLOSPORINE-G PHARMACOKINETICS
    DSOUZA, MJ
    GOURDIKIAN, KB
    MUJUKIAN, AL
    [J]. DRUG METABOLISM AND DISPOSITION, 1988, 16 (06) : 895 - 897
  • [6] PHARMACOKINETICS OF CYCLOSPORINE-A IN 16 NEWBORN-INFANTS OF RENAL OR CARDIAC TRANSPLANT MOTHERS
    CLARIS, O
    PICAUD, JC
    BRAZIER, JL
    SALLE, BL
    [J]. DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS, 1993, 20 (3-4): : 180 - 185
  • [7] THE PHARMACOKINETICS OF CYCLOSPORINE-A IN UREMIC PATIENTS
    LINDBERG, A
    ODLIND, B
    TUFVESON, G
    LINDSTROM, B
    GABRIELSSON, J
    [J]. TRANSPLANTATION PROCEEDINGS, 1986, 18 (06) : 144 - 152
  • [8] THE PHARMACOKINETICS OF CYCLOSPORINE-A WITH SPECIAL EMPHASIS ON BIOAVAILABILITY
    LINDBERGFREIJS, A
    [J]. ACTA PHARMACEUTICA NORDICA, 1992, 4 (03): : 190 - 191
  • [9] PHARMACOKINETICS AND HEPATIC-EFFECTS OF CYCLOSPORINE-A
    CADRANEL, JF
    BABANY, G
    OPOLON, P
    ERLINGER, S
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1992, 16 (04): : 314 - 321
  • [10] NIFEDIPINE, VERAPAMIL AND CYCLOSPORINE-A PHARMACOKINETICS IN CHILDREN
    OGBORN, MR
    CROCKER, JFS
    GRIMM, PC
    [J]. PEDIATRIC NEPHROLOGY, 1989, 3 (03) : 314 - 316